# Dsquared Pharmaceuticals, Inc. – FDA Inspection, Feb 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/dsquared-pharmaceuticals-inc/3f78e0df-112d-4df4-9ed0-2a363c5582e3
Source feed: FDA_Inspections

> FDA inspection 1040843 of Dsquared Pharmaceuticals, Inc., February 13, 2018. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040843
- Company Name: Dsquared Pharmaceuticals, Inc.
- Inspection Date: 2018-02-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gloria-j-baca/1b8c62dc-3195-4364-924d-1d53dd6a7f60)

Company: https://www.keypedia.com/companies/dsquared-pharmaceuticals-inc/d02a55d6-8616-4635-906a-1c70f749fe0d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c